- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04538365
Pre-surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60%
October 30, 2020 updated by: Ricardo Becerro de Bengoa Vallejo, Centro Ortopedico y Quirurgico del Pie
Effect on the Reduction of Bacterial Load in Surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60% Used as Reference Disinfectant
The present study evaluates the effects of bactericidal load reduction after surgical hand scrub antisepsis using the reference antiseptic product propanol-
1 60% as control versus a surgical hand scrub antisepsis with triclosan 0.5% in order to test if pass the standard european norm 12791.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators conducted a crossover clinical trial to evaluate the antiseptic effectiveness of preoperative surgical scrubbing using propan-ol-1 60% by scrub using the reference antiseptic product propan-ol-1 60% as control versus a surgical hand scrub antisepsis with trocilosan 0.5% in order to test if pass the standard european norm 12791.
Samples will be taken from the hands of each volunteer after a surgical hands antiseptic.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28040
- Facultad de Enfermería, Fisioterapia y Podología
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 56 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants without systemic pathologies, with healthy skin of the hands and short fingernails.
- They do not use substances with antibacterial action.
Exclusion Criteria:
- Taken antibiotics before 10 days of the intervention.
- Wear any jewellery on the hands
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Hand antisepsis with propanolol-1 60%
Effectiveness of pre-surgical hand washing in reducing bacterial load using propanolol-1 60% as control
|
Hand antisepsis by scrub Surgical Hand scrubbing using Propanolol 60% solution both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side
Other Names:
|
|
Experimental: Hand antisepsis with triclosan solution
Effectiveness of pre-surgical hand washing in reducing bacterial load using triclosan 0.5% solution
|
Hand antisepsis by scrub Surgical Hand scrubbing using triclosan 0.5% solution both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of bacterial load immediately after hand scrub
Time Frame: Change from bacterial load at 5 minutes
|
Participants will scrub with the antiseptic solution vigorously from hand to the wrists according with the standard handscrub procedure
|
Change from bacterial load at 5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of bacterial load after 3 hours of hand scrub
Time Frame: Change from bacterial load after 3 hours
|
Participants will scrub with the antiseptic solution vigorously from hand to the wrists according with the standard handscrub after 3 hours
|
Change from bacterial load after 3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ricardo B Becerro de Bengoa Vallejo, PhD, Universidad Complutense de Madrid
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2020
Primary Completion (Actual)
October 20, 2020
Study Completion (Actual)
October 30, 2020
Study Registration Dates
First Submitted
August 29, 2020
First Submitted That Met QC Criteria
August 29, 2020
First Posted (Actual)
September 4, 2020
Study Record Updates
Last Update Posted (Actual)
November 2, 2020
Last Update Submitted That Met QC Criteria
October 30, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic beta-Antagonists
- Adrenergic Antagonists
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Vasodilator Agents
- Anti-Infective Agents, Local
- Anti-Infective Agents
- Antimetabolites
- Hypolipidemic Agents
- Lipid Regulating Agents
- Fatty Acid Synthesis Inhibitors
- Propranolol
- Pharmaceutical Solutions
- Triclosan
Other Study ID Numbers
- RICBEC1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
A number will be assigned to each participant
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antisepsis
-
Centro Ortopedico y Quirurgico del PieUnknown
-
Centro Ortopedico y Quirurgico del PieCompleted
-
Prep Tech, LLCCompletedTime Saved Performing Skin Antisepsis Process Outside the OR | Antisepsis of Skin Preparation Outside the ORUnited States
-
Universidade do Vale do SapucaiCompletedAnesthesia, Epidural | Anesthesia, Spinal | AntisepsisBrazil
-
AGUNCO Obstetrics and Gynecology CentreCompletedAntisepsis Regimen After Surgical Treatment of HPV Infected LesionsItaly
-
Ikechukwu Bartholomew UlasiCompleted
-
Alaattin KarabulutActive, not recruitingCystoscopy | Laparoscopic Hysterectomy | Postoperative Urinary Tract Infection | AntisepsisTurkey (Türkiye)
Clinical Trials on propanolol
-
Unity Health TorontoWithdrawnEndoscopic Ultrasound | Gastric Varices Bleeding
-
Yaounde Central HospitalCompleted
-
Instituto Nacional de Ciencias Medicas y Nutricion...Unknown
-
Institute of Liver and Biliary Sciences, IndiaUnknownPortal Hypertension, Biliary AtresiaIndia
-
Texas Tech University Health Sciences Center, El...Terminated
-
University of North Carolina, Chapel HillCompleted
-
University of North Carolina, Chapel HillCompletedInflammation | Stress, Psychological | Cortisol | Sympathetic Nervous SystemUnited States
-
New York State Psychiatric InstituteWithdrawn
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)TerminatedPost-Traumatic Stress DisorderUnited States
-
Universidad Complutense de MadridCompletedSkin Diseases | Surgical Site InfectionSpain